PWRM, Power 3 Medical Products Inc., PWRM.OB
PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.
PWRM's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).
PWRM continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS (Lou Gehrig's disease), Alzheimer's, Parkinson's diseases, breast cancer, and drug resistance.
The NuroPro Blood Test is PWRM's diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease .
PWRM's BC-SeraPro(TM) is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient's serum sample is compared to PWRM's patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis. Probability score is ranged from 0.0 to 1.0. Results of PWRM's BC-SeraPro(TM) test should not be considered a stand alone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.
PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer's disease (NuroPro-AD), Parkinson's disease (NuroPro-PD) and breast cancer in 2010, followed by filings with the FDA.
The American Cancer Society's most recent estimates for breast cancer in the United States are for 2009: 192,370 new cases of invasive breast cancer and 40,170 deaths from breast cancer
Breast cancer is the most common cancer among women in the United States, other than skin cancer. It is the second leading cause of cancer death in women, after lung cancer. The chance of a woman having invasive breast cancer some time during her life is a little less than 1 in 8. The chance of dying from breast cancer is about 1 in 35.
Breast cancer death rates have been going down. This is probably the result of finding the cancer earlier and providing better treatment. Right now there are more than 2½ million breast cancer survivors in the United States. (SOURCE: CLICK HERE)
Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
More about PWRM at www.power3medical.com
Harry W. Buckley, president and chief executive officer of Jackson Hewitt Tax Service Inc. (Jackson Hewitt) (NYSE:JTX), made the following statement in reaction to the announcement by the Internal Revenue Service (IRS) that the debt indicator will be eliminated for the 2011 tax season:
The IRS decision to not provide debt indicator data to taxpayers through the electronic tax filing process will make it difficult for the millions of taxpayers who desire to receive cash quickly in connection with the electronic filing of their annual tax return. However, from the taxpayers' perspective, it will likely become harder to receive credit approval, will cost more and the amount of credit available may be limited all negative impacts on taxpayers during this difficult economic environment, and all a direct result of the unilateral action taken by the IRS today.
Jackson Hewitt Tax Service Inc. (NYSE:JTX), with more than 6,400 franchised and company-owned offices throughout the United States in the 2010 tax season, is an industry leader providing full service individual federal and state income tax return preparation. Most offices are independently owned and operated. Jackson Hewitt also offers Jackson Hewitt® Online, an online tax preparation product available at www.jacksonhewittonline.com. The company is based in Parsippany, New Jersey. More information may be obtained at www.jacksonhewitt.com. To locate the Jackson Hewitt Tax Service office nearest to you, call 1-800-234-1040.
TAXS, TaxMasters, Inc., TAXS.OB
The Internal Revenue Service (IRS) hangs like a threatening cloud over the heads of tens of thousands of taxpayers every year who find themselves swimming against the overpowering current of the IRS collections process.
Federal tax debt is serious and the IRS is a terrifying opponent for anyone with tax problems. The IRS is known to use questionable audit tactics, garnish your wages, put liens on your property, and levy the money in your bank accounts to satisfy your tax debt. And if they think you are intentionally withholding information or revenue, they can drown you with charges of evasion and even fraud.
TAXS can get between you and the IRS.
TAXS, the IRS tax relief company, is the first publicly traded tax representation firm in the United States.
TAXS reported that through the Offer in Compromise program with the Internal Revenue Services, it has saved clients a total of $704,000 in the first quarter of 2010.
In the first quarter of 2010, TAXS' clients owing over $770,000 in past due taxes and accrued penalties, submitted Offers in Compromise that were accepted by the IRS. The accepted offers resulted in TaxMasters clients paying less than 10 percent of the actual tax liabilities owed.
Through its knowledgeable staff, TAXS was able to settle significant individual and small business tax debts through effective negotiations with the IRS.
TAXS professionals walk each client through his or her individual case, acting as a liaison between the client and IRS personnel to find financially manageable tax resolutions.
Many with IRS tax debt don't realize there are over 100 steps involved in completing an Offer in Compromise with the IRS, says Renee Miller, vice president of tax services at TaxMasters. TaxMasters continues to have outstanding success getting clients back into compliance with the IRS, determining if they qualify for a settlement, and finally helping them effectively prepare and submit quality Offers in Compromise.
An Offer in Compromise is an agreement between a taxpayer and the government where the government accepts payments of less than the full tax debt in exchange for the taxpayer's promise to abide by tax laws for at least five years.
According to the National Taxpayer Advocate 2009 Annual Report to Congress, lawmakers have repeatedly encouraged the IRS to be flexible in finding ways to work with taxpayers who are sincerely trying to meet their obligations and remain in the tax system.
In conjunction with Offers in Compromise, TAXS provides clients with a suite of tax offerings and services, including tax preparation, strategic advocacy and client audits.
Established in 2001, TAXS has represented its clients in various tax crises, focusing on helping clients regain compliance, re-enter the tax system, settle outstanding tax debts, as well as negotiate payment plans.
With an increasing number of Americans facing tax debt, TAXS has grown exponentially over the last seven years, taking the IRS tax representation firm from six employees to over 300.
More about TAXS at www.txmstr.com.
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)Crown Equity Holdings Inc. (CRWE.OB) has previously received twenty four thousand dollars from Tax Masters Inc.(TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings Inc. (CRWE.OB) has received four thousand dollars from a third party (Marshall Curtis) for 30 days of advertisement for services for Tax Masters Inc.(TAXS.OB) which has expired. Crown Equity Holdings Inc. has received an additional four thousand dollars from the same third party (Marshall Curtis) for an additional 30 days of advertisement services.